🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Indorama Ventures PCL (BKK:IVL)
Thailand flag Thailand · Delayed Price · Currency is THB
21.75
0.00 (0.00%)
Nov 18, 2026, 4:35 PM ICT
← View all transcripts

Earnings Call: Q3 2026

Nov 9, 2026

Summary

9M EBITDA rose 63% to THB 43.5B as management actions and favorable markets lifted profitability despite lower volume. FY 2026 EBITDA guidance is THB 54B–56B, with cash generation and divestments supporting debt reduction.

Operator

Good morning, everyone, and thank you for joining us today for Indorama Ventures' third quarter 2026 results briefing. I am Boriboon Sangiambut , moderating this call. Opening the presentation today will be Ms. Aradhana Lohia Sharma. Then our CFO, Ashok Jain, will take us through the IVL financials and highlights of our key management actions. Our segment leaders, Muthukumar Paramasivam, President CPET, Sunil Marwah, President Indovida, Alastair Port, Executive President Indovinya, Diego Boeri, Executive President Fibers, will then take us through the performance of their respective businesses. Following the prepared presentation, we will open the floor for Q&A.

Before we begin, please note that this meeting is being recorded and a replay will be available on our website following the session. Also note that today's presentation includes certain assumptions and forward-looking estimates based on our current industry and business outlook, as well as the information available to us at this time. Over to you, please, Khun Aradhana.

Aradhana Lohia Sharma
VP, Indorama Ventures

Welcome, everyone, and thank you for joining our third quarter results briefing. Before we go into the numbers, I would like to set out the four messages that frame today's presentation. Over the first nine months of 2026, our performance has improved substantially. Favorable market conditions have supported that improvement alongside deliberate management actions to strengthen competitiveness, improve earnings quality, and generate cash to reduce debt. It is important to understand both contributions as we look at this year's results and the outlook ahead. First, our global platform and local-for-local model continue to demonstrate their value. IVL's business model has been built along one principle: to be close to customers and suppliers. This year, having production close to customers supported by access to feedstocks has helped us maintain reliable supply through volatile trade flows and disruption.

The conflict in Iran has strengthened the relative position of local producers, and IVL has benefited from that positioning. We recognize that some of these market benefits will moderate. Our focus is on ensuring that the improvements within our control continue to strengthen the business as they do. Second, we are improving the quality of our earnings. Nine-month EBITDA increased 63% to THB 43.5 billion, with 5% lower sales volume. That reflects stronger profitability per ton, supported by market conditions and progress under our five enterprise priorities. We are creating a more competitive footprint and lowering fixed costs. Commercial and manufacturing excellence are improving sales realization, procurement, yields, and reliability. Tighter inventory discipline means we are aligning production more closely with sales and working capital requirements, bringing in further efficiency and also less exposure amid volatile price movements. Progress is not uniform.

The Americas and Asia led the earnings improvement, while Europe remains our most challenged region and a priority for further action. Third, stronger cash generation is supporting deleveraging. Operating cash flow after maintenance Capex reached THB 34.5 billion in the first nine months, equivalent to approximately 80% of EBITDA. Net debt declined by approximately THB 19 billion year on year. Inventory turns improved from 4.7 to 5.2x , and we are targeting 6x . This discipline is particularly important when higher feedstock prices increase the value of inventory. Together with portfolio disposals and improved financing efficiency, it supports our priority of converting operating progress into lower debt. Finally, we remain confident in our outlook and our CMD commitments. We expect full year 2026 EBITDA between THB 54 billion and THB 56 billion, approximately 20% above the Capital Markets Day plan we presented earlier this year.

Looking into 2027, further management improvements, recovery in parts of the business, and our packaging consolidation in India support that confidence. We remain committed to the 2027 CMD milestone and our 2028 targets to double EBITDA and reduce net debt to EBITDA to 3x or below. The focus throughout today's presentation is how these actions are improving performance, what remains to be done, and how we will translate that progress into cash, lower debt, and better returns. Now I will pass it over to Ashok, who will take us through the details of our progress.

Ashok Jain
CFO, Indorama Ventures

Thank you, Aradhana. Good morning to all, and a very happy Diwali. This is the beginning of the Hindu calendar year. On this slide, I will cover the nine-month results. In the first nine months of 2026, EBITDA rose 63% year on year to THB 43.5 billion. EBITDA per ton increased approximately 75% year on year, and the EBITDA margin widened to 11% from 8%. This is on 5% lower sales volume. Lower volumes partly reflect capacity rationalization under IVL 2.0 and our decision to align production with sales and inventory targets. Net profit before impairments and exceptional items was THB 9.8 billion, equivalent to EPS of THB 1.63, compared with a loss of THB 2.6 billion a year earlier.

Our average quarterly net finance costs decreased to THB 3.1 billion from THB 3.6 billion in 2025, which is a reflection of our lower debt and lower borrowing rates. The Americas and Asia led the nine-month earnings improvement, with EBITDA rising by 49% year on year to THB 29.1 billion in Americas and 56% to THB 12.3 billion in Asia. Both remained substantially above prior year earnings in the third quarter, as market benefits seen in second quarter 2026 moderated. Europe remains our most challenged region and is a priority for further improvement. Moving to the next slide on management actions. This slide sets out the four areas of management action supporting our confidence in delivering the 2027 targets. These actions are already underway, and each has a clear role in improving earnings, releasing capital, or strengthening cash generation.

The first is to execute the asset rationalization plan. We are completing divestments and closures of our manufacturing sites to move production to more competitive sites and accelerating decisions on operations that need to be fixed or exited. The objective is to concentrate resources in businesses that can earn sustainable returns while removing residual costs and releasing capital from assets which we no longer need. Secondly, continuously improve the cost and performance of our existing asset base. Footprints changes are only part of the work. Across our continuing operations, we are improving fixed cost productivity, procurement efficiency, and manufacturing yields. Better commercial terms and sourcing to improve the value we capture, while higher yields and reliability, which help us to produce more efficiently. These improvements strengthen earnings alongside changes in the market spreads. Thirdly, we have been pursuing selective growth as far as our capital allocation is concerned.

We are focusing on projects and partnerships that strengthens our businesses and where we have a clear competitive position. Our packaging consolidation in India under our segment of Indovida is an important example. In Fibers, we also see opportunity to grow our hygiene business in the Americas, building on strong demand and the operational improvements already delivered there. The emphasis is on sustainable earnings, synergies, and returns, with capital discipline guiding our choices. At the same time, we maintain our cash and capital discipline. We are linking our portfolio investments to release of funds through divestments and better working capital management. Tighter coordination of purchasing, production, and sales helps reduce the capital tied up in the business and improves the cash conversion. These four areas work together to further improve the quality of earnings, a more competitive portfolio, better performance from existing assets, selective growth, and disciplined funding.

Their contribution is central to delivering our 2027 commitments while continue to reduce debt. On this slide, just taking cue from what is stated on the previous slide, as examples. On the portfolio actions, we are creating a more competitive footprint, lowering recurring costs, and releasing capital. Higher Western production costs and persistent petrochemical overcapacity have required decisive actions. We have concentrated production in more competitive operations and addressed assets that could no longer deliver acceptable returns. We have completed actions across 10 manufacturing sites through four divestments and six rationalizations, which represents approximately 3.4 million tons of capacity. By doing these actions, it brings in three distinct financial effects. We have taken approximately THB 35 billion of non-cash impairments, which reflects the reduction in our carrying value for the assets.

We have provided and spent around THB 5.5 billion in one-time cash expenses towards severance and other activities relating to the sites which have been rationalized. The program has also reduced fixed costs by approximately THB 5.4 billion on an annual basis, strengthening our recurring earnings space. The operating benefits comes from transferring production to more competitive sites and removing costs from the sites which have been rationalized. Dispositions are continuing operations to improve utilization and returns. Europe is an important part of this story. It has been substantial restructuring, and we now have a lower fixed cost base. Although profitability remains under pressure, with an expectation of an end to the conflict in Iran, which should ease raw material sourcing premiums and energy costs, that would allow more of the benefit from our portfolio actions to come through in earnings.

The combination of management improvements and potential cost relief supports our confidence in better European performance in 2027. These portfolio actions have released cash for us. We have completed the divestment of our equity stake through a sale of our airbag operation, which has generated THB 650 million in cash, which will be recognized in the fourth quarter. Further, THB 6.6 billion is expected from assets held for sale during 2027 and 2028. There have been delays in this process, but we continue to work on this and to realize this cash. These actions support our CMD commitments through a lower recurring cost base, better returns from our continuing assets, and disposal proceeds that will support our capital priorities and debt reduction. This slide again reflects on the reduction in our fixed cost for IVL on a consolidated basis.

We expect fixed costs in 2026 to be approximately 12% below 2023, despite three years of inflation. Our fixed cost in 2023 was at THB 84 billion. The inflation would have added approximately THB 7.4 billion from end of 2023 till 2026, taking our cost base to around THB 91.4 billion without the offsetting actions which we have taken. Our transformative initiatives have removed approximately THB 12 billion through organizational efficiency and productivity improvements. Asset optimization has removed a further THB 5.4 billion, reflecting the footprint actions discussed on the previous slide. Together, these actions have more than offset inflation, bringing our estimated fixed cost for 2026 to THB 74 billion. The important distinction is between the savings delivered and the net reduction after inflation.

We have delivered THB 17.4 billion of reductions, part of which has absorbed inflation while still lowering our absolute cost base. This is a measurable contribution from management actions that remains as market spreads normalize. It also means that as we improve utilization across our continuing operations, we can spread this lower fixed cost base over more production volumes, which will improve our unit costs and support earnings. The next slide is an illustration of how our actions on the working capital management has benefited us in the current environment. We saw in 2022, crude prices increase by 11%, which resulted in increasing our working capital by 4%, and this resulted in an outflow of THB 2 billion. During this time, our inventory turns decreased from around 5x to 4.4 x.

Our net debt decreased by THB 17 billion, which was driven primarily by the higher performance during that time in a favorable environment. This time around in 2026, we have seen a similar situation, but where crude prices have risen more sharply by 34%. But with our actions, we have been able to decrease our working capital by THB 15 billion, which has resulted in our net debt to decline by THB 19 billion year on year. Our inventory turns have improved from 4.5 x to 5.3 x. This is an important change in the discipline which have been brought in through S&OE, where we are aligning procurement and production more closely with our sales commitments. We have been willing to constrain production where necessary to control inventory exposure and to release cash flow.

That discipline matters because higher feedstock prices would otherwise increase the capital needed to run the business. Holding less inventory relative to activity also reduces our exposure to price movements. This is tangible evidence of our management actions. We are releasing working capital despite higher feedstock prices in the current year, which is helping converting earnings into cash and reduce debt. Our next objective is to move towards inventory turns of 6x while maintaining reliable service to our customers. On this slide, it is our waterfall for the cash flow. Over the 12-month period from end of September 2025 to end of September 2026, we have reduced net debt by THB 19.4 billion. Our net debt at the end of September 2026 is THB 223.7 billion.

During this 12-month period, our operating cash flow after maintenance Capex reached THB 45.5 billion, equivalent to 95% of EBITDA, supported by earnings and release from working capital. Our net debt to equity has decreased from 1.74 x to 1.52 x, while our net debt to EBITDA has decreased from 6.6 x to 4.7 x on last 12-month basis. To remind you, this 4.7 x is after taking into account fourth quarter 2025, which was our lower quarter for EBITDA. We expect further improvement in our leverage ratios by the end of the year. The key message is that operating performance and capital discipline are translating into lower debt. Sustaining that cash conversion remains central to deliver on our CMD commitments. Moving to the next slide. With the reduction in debt, it has also resulted in decrease in our financing cost.

Our average quarterly financial cost has declined from THB 3.6 billion in 2025 to THB 3.1 billion in the first nine months of 2026. This represents approximately THB 2 billion of savings on an annualized basis towards interest expenses. The improvement comes from both lower debt and lower borrowing rates. Our interest rate measured on a trailing 12-month basis decreased from 5.7% in 2025 to 5.1%, supported by funding optimization and proactive debt management. This reinforces the benefit of our cash and capital discipline. Strong cash generation reduces debt, which in turn lowers financing cost, which results in lower cash outflow, which will assist in further deleveraging. Moving to the next slide.

As illustrated on our previous slides, the management execution position at IVL will allow us to deliver on our 2027 commitments, and we are confident to deliver the 2027 targets with the performance we are already seeing. The third quarter EBITDA was approximately THB 13.7 billion, with inventory gains and price lag losses broadly offsetting at IVL consolidated level. On an annualized basis, that is already close to the earnings level required for our 2027 commitment. We recognize that the earnings mix will change. Some businesses will normalize from elevated level, while others will contribute more. The important point is how those movements come together across IVL. In our Combined PET business segment, or CPET, the vertical spreads are stabilizing above 2025 levels. Following our strategic review, we are retaining the businesses under review and focusing on improving their operational performance and returns.

In our Fibers business, we expect profitability to recover. We expect margin and volume pressures to ease in lifestyle and mobility, while our U.S. hygiene business is positioned for growth. For Indovinya and Indovida, we look at their combined contribution. Indovinya's third quarter earnings represent an annualized EBITDA run rate of approximately THB 17 billion. We are allowing for moderation from the elevated level as market conditions normalize while retaining the benefits of commercial and operational improvements. At the same time, in our Indovida business segment, with the consolidation of EPL, which remains on track to close in the first quarter of 2027, we have been steadily making progress on regulatory approvals, and which is going as per plan. In 2027, we expect to nearly double Indovida's EBITDA on a full-year basis. We expect Indovida's increased contribution to offset the normalization in Indovinya.

Our confidence there, therefore, does not depend on Indovinya repeating its strongest quarter throughout next year. Europe also offers scope for recovery. We have already lowered the cost base through restructuring. With the Iran conflict easing, which will reduce premiums on sourcing and decrease energy costs, which will allow for more benefits to come through in earnings in 2027. Across the group, we expect operating rates to improve in 2027 from 2025 levels. Our operating rate has been around 75%, so we are looking to move our operating rates towards 80%, supported by better reliability and disciplined production planning. Higher utilization of our more competitive footprint should further improve our unit costs and cash generation. All of this will offset, and operating improvements underpin our confidence in delivering the 2027 commitment while continuing to reduce debt.

Our priority is to execute these actions and translate stronger operating performance into cash and better returns. Moving to our actual performance for the first nine months of 2026, IVL has delivered an EBITDA of THB 43.5 billion, an increase of 63% year-on-year. The improvement was led by CPET and Indovinya, with Indovida also contributing in the growth. Fibers remains below the prior year, reflecting continued challenges in lifestyle and mobility. The regional picture shows the breadth of the improvement. Americas EBITDA increased approximately 49% to THB 29.2 billion, while Asia grew 56% to THB 12.3 billion. EMEA recovered to THB 4.4 billion, which is an increase from approximately, sorry, from approximately THB 0.9 billion. Although, as stated earlier, we continue to look at improving our performance in Europe. These results reflect both favorable market conditions and management actions.

Our local-for-local positioning supported by our customers, while our portfolio rationalizations, lower fixed cost, and commercial and manufacturing improvements have strengthened the performance. The third quarter EBITDA remains 65% above the previous year. Our third quarter EBITDA is at THB 13.7 billion, demonstrating continued improvement as the exceptional second quarter market benefits moderated. Our focus is on sustaining that progress and converting earnings into cash and lower our debt. Our business leaders will explain the operating actions and regional developments across their respective business segments. With this, I would like to hand over to Muthukumar to walk you through Combined PET business segment.

Muthukumar Paramasivam
President of CPET, Indorama Ventures

Thank you, Ashok. [Non-English content] . Good morning, everyone. For Combined PET, third quarter 2026 EBITDA was THB 8.7 billion, up 88% year-over-year, demonstrating continued resilience as market conditions normalized from an exceptional second quarter 2026. Looking at integrated PET, it delivered EBITDA of THB 4.9 billion, up 39% year-over-year. This increase was supported by stronger benchmark integrated PET spreads, which actually increased from $113 per ton in the third quarter of last year to $176 per ton this year, and have since stabilized around this level. Better industry discipline, limited new capacity additions, as well as reduced access to discounted crude for Chinese refineries, these factors have led to the stabilization of these spreads.

Looking at our intermediate chemicals, it delivered EBITDA of THB 3.3 billion, improving significantly from THB 646 million in third quarter of last year, benefiting from stronger MTBE and integrated EG spreads, as well as higher EG volumes following a TAR we had in the third quarter of 2025. CPET portfolio having the natural operational hedge between our MTBE and the mixed xylene that we are sourcing for our PX production, that is helping us to reduce volatility in our overall segment earnings. Specialty chemicals vertical of CPET contributed EBITDA of THB 418 million, compared with THB 456 million in third quarter of 2025, and THB 1.1 billion in second quarter of 2026. Year-on-year, NDC performed better. PIA was impacted due to high energy and feedstock disparity, while specialty polymers was flat.

Regionally, while both Americas and Asia have shown material improvement year-over-year performance during third quarter, EMEA region continues to be challenged due to high energy and feedstock disparity, as you can see in this chart. While we expect improvement in both these factors as the Iran war eases, and in parallel, we are also undertaking other cost pass-through actions, the initiation of a safeguard investigation last week by the European Commission on the PET value chain, including PIA, this is an important event contributing towards the future performance of the European region. With respect to the three assets of strategic review under CPET, which would be our complex PET, PTA, and PIA complex in Spain, our specialty polymers portfolio, as well as the integrated EG, from the strategic review, we have concluded to retain and continue operation of these assets.

We have identified specific actions to further improve performance and quality earnings of each of these businesses. Overall, third quarter 2026 demonstrates the resilience and balance of CPET's integrated portfolio as the exceptional second quarter conditions normalized. Continued focus on operating discipline, S&OE, inventory and working capital management, commercial execution, and cost actions, these are helping to strengthen the earnings quality as well as cash conversion. We remain confident of translating these actions and our Q3 delivery into consistent through cycle performance and on track to meet our 2027 CMD targets. That's on CPET. With that, I'll pass it over to Sunil. Thank you.

Sunil Marwah
President of Indovida, Indorama Ventures

Thank you, Muthu. [Non-English content] Good morning. Indovida reported an EBITDA of THB 1 billion in third quarter 2026, with an EBITDA margin of 21%. Continued operational discipline supported profitability during the quarter. EBITDA increased by 45% year-on-year, with management self-help initiatives contributing approximately 50% of this improvement and supporting sustained profitability. Commercial excellence initiatives and the continued ramp-up in Tanzania supported a 10% increase in sales volume, while commercial excellence also delivered sustained margin improvements. The remaining approximately 50% of the EBITDA increase reflected margin improvement and inventory restocking by brand owners amid the ongoing Middle East conflict. On a quarter-on-quarter basis, EBITDA normalized after the exceptional market tailwinds in quarter two 2026 and normal seasonal factors. Overall, Indovida's performance reflects strong profitability, improved returns, and healthy cash generation. This, alongside the progress in strengthening our digital systems, is helping the operations.

Going forward, the focus remains on sustained operating performance and disciplined execution of growth initiatives that we are undertaking, prudent capital allocation, advancing digital capabilities, and unlocking cash opportunities to support long-term creation for our investors, value creation for our investors. Thank you. I pass it on to Alastair.

Alastair Port
Executive President of Indovinya, Indorama Ventures

Hi. Thanks, Sunil. Hi. Good morning, everyone. Indovinya's quarter three 2026 EBITDA of THB 4.2 billion increased by 64% year-on-year, with an overall EBITDA margin of 17.4% and HVA margins of 18.2%. HVA accounted for 83% of Indovinya's EBITDA. Revenue of THB 24.4 billion increased 19% year-on-year, with HVA products generating 79% of the total. Results continue to be driven by effective commercial execution, structural improvements, and favorable market conditions. On a year-on-year nine-month basis, Indovinya's EBITDA of THB 10.6 billion increased by 32%, demonstrating ongoing strong performance and ahead of our CMD targets. With our concentration in Americas and growing presence in Asia, 90% of our products are sold into consumer-led end markets, which benefit from our local-for-local and geographically advantaged production.

Our management teams continue to focus on transformation initiatives, leveraging commercial excellence and innovation to drive earnings, procurement excellence to manage our variable costs, and manufacturing excellence to improve available volumes and costs, while our S&OE discipline continues to align production and demand and improve our net working capital efficiency and inventory turns. Thank you. I will hand it over to Diego.

Diego Boeri
Executive President of Fibers, Indorama Ventures

Good morning. For Fibers, Q3 EBITDA was THB 924 million, broadly flat year-on-year. For the first nine months, total reported EBITDA was THB 3,676 million, down 7.3% year-on-year. The performance is significantly different by region. In the Americas, our year-to-date EBITDA rose 47% to THB 884 million. Our hygiene business drove the improvement. EBITDA increased 54% year-to-date on a 2% volume growth, supported by steady essential consumer demand, our strong U.S. market position, and a richer mix. We have also improved yield and quality in our fiber assets in the Americas. Our priorities are to ramp up our recent U.S. hygiene investment in North Carolina, in Mocksville, continue to improve yields and drive more specialty mix by transferring some higher-margin products from Europe. We plan further equipment upgrades in our Riga factory, which will go through a full turnaround in 2027.

We are also actively considering M&A option to further strengthen our market position in hygiene. In EMEA, the situation is different. Our year-to-date EBITDA improved to THB 866 million from THB 430 million the year before, led by hygiene and mobility. This was a recovery for a depressed base supported by pricing discipline, mix, lower-cost inventory, and operational improvement, not a broad market recovery. However, Q3 moved to a THB 118 million loss as Q2 inventory benefits did not reoccur, and margin compressed, mainly mobility and hygiene. Lifestyle and wool also weakened. Year-to-date volume fell 16%, underscoring continued pressure. High energy costs, Chinese competition, and a high fixed cost footprint require more structural action. Our priorities are to lower the cost and asset base, accelerate fix or exit decision, recover input cost inflation through disciplined pricing, and focus on differentiated higher-margin application in mobility and hygiene.

In Asia, our year-to-date EBITDA fell 34% to THB 1.9 billion, with volume down 15.4%. Due to the war, raw material escalation, lifestyle faced weak textile demand, inventory caution, and substitution toward cotton and blends. Its regional EBITDA declined 44%. In mobility, additional Chinese tire cord capacity is pressuring margin. EBITDA fell 34% despite volume growth of 2.3%. We are operating to demand, reducing low contribution export, controlling inventory and cost, and developing specialty opportunities in India. Going forward, we expect the textile demand to come back and the PSF margin to improve, as it is already happening in Q4, and therefore rebound to more normal levels. Despite earnings pressure, cash and cost action are delivering tangible results. Net working capital declined from THB 7.9 billion in June to THB 5.7 billion in September, a THB 2.2 billion release. Year-to-date fixed cost productivity reached THB 0.4 billion, excluding discontinued operation.

These improvements strengthen liquidity and support the funding of portfolio action, while further inventory and cost discipline remain priorities. Our agenda is regional execution with common capital discipline, scale profitable hygiene growth in North America as a priority, rebound contributor in Asia, particularly in lifestyle, and continue to rationalize the EMEA footprint. Across all regions, we will optimize cost and assets, invest selectively, and fund the transformation through divestment and better working capital management. Based on all this action, we are looking at 2027 with optimism and are confident to deliver the growth plan presented at the CMD.

Aradhana Lohia Sharma
VP, Indorama Ventures

Before we move to questions, let me bring together the key messages from today. Our global platform continues to demonstrate its value. Our local-for-local model has helped us serve customers reliably through trade and supply disruptions, reinforcing the importance of our regional presence and access to feedstocks. We are also strengthening the business through our own actions. As you have heard today, portfolio rationalization, lower fixed costs, specific commercial and manufacturing improvements within each segment, and tighter inventory management are contributing to better performance. Favorable market conditions have helped, but the progress we are making extends beyond those benefits. That progress is translating into cash and lower debt. Net debt declined by close to THB 20 billion over the 12 months to September. Financing costs are falling, and debt reduction is tracking ahead of plan.

For 2026, we expect our EBITDA in the range of THB 54 billion-THB 56 billion, approximately 20% above our Capital Markets Day plan. Looking ahead, we remain confident in delivering our 2027 target. We recognize that the earnings mix will change as some market benefits normalize. Our confidence reflects the growth and operating improvements across the portfolio that we expect to offset those pressures. Our focus remains clear: deliver the improvements within our control, convert earnings into cash, reduce debt, and improve returns, structurally improving our portfolio. Thank you for joining us today. We would now be pleased to take your questions.

Operator

Thank you, everyone. I think we now open the floor for questions.

Komsun Suksumrun
Analyst, Bank of America and Phatra

Hello, can you hear me? This is Komsun from Bank of America and Phatra.

Operator

Yes, we can hear you, Khun Komsun.

Komsun Suksumrun
Analyst, Bank of America and Phatra

Thanks for the thorough presentation. Congratulations on your self-help initiations that started to bear fruit. I would like to ask, could you add more color on the further action in 2027 that Ashok mentioned that there is assets to be sold THB 6.6 billion in that year? Could you add more color which sort of I understand that Europe is sort of a problem with the high cost and everything, and Fibers seems to be the focus. Can you add more color on that? The other thing is that on the IVOG and IVOL, I understand that you decided to I mean, the restructuring plan has The decision has been completed. What can you do on those two assets, and what was the performance in the third quarter? Thank you.

Aloke Lohia
CEO, Indorama Ventures

Okay. I think, well, Ashok will answer the question on the Maybe on the IVOG, IVOL, we went through a thorough 12-month review of the operations, and that business comes under CPET, but the manufacturing part of IVOG and IVOL is done by Alastair's team. So I would like Alastair to explain on what we have done over the last 12 months and what is our confidence level of those two assets going forward, because the reliability has been one of the factors. On the economics of that business, maybe Muthu can explain what has changed. Not only is that asset, we had three assets that were up for review. We had a PTA PIA business in Europe, and that has also gone through a favorable review. That business, because of its strategic nature and its ability to generate cash, will be retained.

Then finally, there was a business of specialty polymers. As you would see from the results, these businesses have not been delivering higher value as traditionally. So a whole review has gone through with these businesses, and certain fixes are possible, and we have identified and we have approved those Capexes, whether it's maintenance-related or growth-related to those sites. So Muthu will cover based on the commercial reasons why we are retaining these assets, and Alastair will help us understand the reliability factor of those two assets. Go ahead, Ashok.

Ashok Jain
CFO, Indorama Ventures

Komsun, on your question on the assets held for sale, these are the properties which we own of the assets which we had shut down in Rotterdam, the PET PTA plant, the Canada PTA, then the Australia surfactants business. So we have been in the process of these divestments, plus some of the other sites which we have shut down. So these are transactions in progress, and we expect to realize cash of THB 6.6 billion in 2027/2028. In fourth quarter 2026, the cash realization of THB 650 million will get reflected on the sale of our 50% equity stake in a joint venture for airbag operation.

Alastair Port
Executive President of Indovinya, Indorama Ventures

Hi. So in terms of the operation of the assets, I think IVL follows a well-honed process of how to improve base reliability through team structures, through processes, and through assets investment. That's the process we're covering on both IVOL and IVOG on the ethylene cracker and the EOEG assets. I think we're making some very good progress. As Muthu said, the turnaround in quarter two is behind us on IVOG, and we're now seeing a much more stable operations. On IVOL, we've got a turnaround coming up in 2027, at the end of the first quarter, and that's going to improve some of the base assets there. But alongside that, our reliability systems, our team structures are all in place, and I think we're seeing some very, very good results as a result of that. The other part of that process is Project Rebound.

Project Rebound is about how do we take these assets forward into the next decade, and really ensure that they're moving as a higher value assets as we can. That's going to take some investments on some of the asset portfolio, and it's going to take some investments on some of the systems. We've signed off that we're committed to doing that, and therefore Mr. Lohia has made the decision that these assets are well worth retaining. So the team's very focused. It's got a clear plan, it's got a clear path forward, and it's in implementation today.

Muthukumar Paramasivam
President of CPET, Indorama Ventures

Thank you, Alastair. As far as the integrated EG assets that we are now deciding to retain and continue to operate and improve, on the market and the commercial side, specific actions are being taken. Anywhere from how we are collaborating with our captive, obviously we have a large consumption of glycol globally. The collaboration between our captive and merchant buy and sell, that is a very important factor. How we are taking advantage of the global markets, although our manufacturing base is in U.S., how we are taking advantage of the opportunities globally, including any trade preferences that U.S. has or will be having. That is another aspect that is going to have a positive influence on our sale of these products. The third area is also on our specific cost pass-through actions with our customers.

Specific actions have been taken on that front in terms of how we are structuring the contracts. As well as now talking about the spreads on EG, as all of you would have seen that they have improved, and we do expect them to stabilize better than 2025 levels. We being the only shale-to-PET producer, that shale advantage with the naphtha cracks now being strong, our advantage of the shale, that also increases. These are certain things on the commercial side, on the market approach, go-to-market strategy, that is going to support performance of these assets going forward.

Operator

Thank you. I think we now have a next question from Khun Naphat at CLSA. Khun Naphat, please.

Naphat Chantaraserekul
Analyst, CLSA

Hi, good morning. Thank you for the presentation. I have a follow-up question on the earlier answer on the asset. Did I hear correctly that we might have to put more Capex in terms of to make this asset work again, the asset that we are under review now? If that's the case, how much Capex that we have to put in?

Alastair Port
Executive President of Indovinya, Indorama Ventures

Yeah, the Capex that we are going to invest is still being looked at as we work through the processes. I think when you are looking at it is not Capex to take it up to a low operating rate. We think we can get that by normal reliability improvement methods. This Capex is to take it beyond where we have operated historically and take it to a higher level. I think it is a little bit early to announce the Capex yet. We are still going through the engineering design of it, but we are working through that internally. But if we do invest capital, that is to take it to a higher level from historical operation rates and margin rates.

Aloke Lohia
CEO, Indorama Ventures

Khun Naphat, let me add philosophically. Technology in this business has not changed. The IVOL plant, the IVOG plant uses technology that is used elsewhere too. The difference is the scale that we have in these older assets. But we have this advantage in the entire system, as Muthu was saying about shale-to-PET. Plus, in our IVOG business, we have both our commodity MEG business, but we also have a specialty purified ethylene oxide business. So combined, when we do the ratios, we do, let us say, a focused approach on that combined asset of ethylene and downstream, and then link it to the entire PET value chain. We have seen that the local for local advantage is something that is important, provides us security of supply, and gives us a good overall return for our business.

There is that intense focus on making those assets work and operate at better than our cost of capital. That is how we are looking at it. We are looking at it strategically. Whatever is the required investments to make that happen, we will make it happen because all of that is based on DCF calculation. The risk and rewards are measured simultaneously. These are assets that are difficult to replace, and there is no reason technologically to replace them either.

Naphat Chantaraserekul
Analyst, CLSA

Okay, thank you. I have another few questions. One is on the, I think in the Q3 P&L and also on the cash flow item, that I think we have some item on the impairment, THB 263 million. When I look at the details of the breakdown and I see the restructuring and severance loss about THB 449 million. If you can give us some light on this item, where is it from, and should we expect any more restructuring expenses in Q4?

Aloke Lohia
CEO, Indorama Ventures

Go ahead, Ashok.

Ashok Jain
CFO, Indorama Ventures

Yeah. Okay. What we have done is that we have classified our items. The THB 263 million loss that you see is a combination of THB 243 million from asset impairments, reversal or loss, the divestments gain by loss, and the insurance incomes. The restructuring and severance loss, the THB 449 million is specific to an asset in Europe for the Fibers business, where we have taken the severance provision, and also some of the other sites which we had shut down, there are severance costs or restructuring costs which are being incurred. This is a reference to that THB 449 million. We do not see any major item on this in the fourth quarter 2026.

The third classification is on the forex gain by loss on long-term loans and mark-to-market movements, which is a gain of THB 207 million, and there are other exceptional items. What we have done is, in table seven of the MD&A, we have put down these numbers with these four classification line items, and we will continue to disclose this going forward.

Naphat Chantaraserekul
Analyst, CLSA

Another question is on the balance sheet item. I think this may, just to give us better understanding in terms of our deleveraging plan, because I see the cash item in our balance sheet is at THB 44 billion. Given the oil price is softening now, and also the spread is quite healthy in Q4. My question is, I also see the absolute net debt also down QonQ. Net debt to EBITDA also declining to about 4.7 x, as you mentioned, 4.6, yeah.

My question is, when the oil prices are falling in Q4, and assuming that oil price is at about $80-$90 a barrel, how much do you think we can free up cash from our balance sheet to continue deleveraging into Q4, combining with the asset sales that we are about to realize another THB 660 million from the airbag business? So, I wonder how much cash can we reduce and use it to deleverage in Q4?

Ashok Jain
CFO, Indorama Ventures

To your point, when the oil price will decrease, we will have release from cash flows for the working capital. We will come back with you with a specific number on that release. Then with the THB 635 million cash realization from the divestment of equity stake, all of this will decrease our debt. We do expect our net debt to EBITDA ratio to further decrease at the end of 2026.

Aloke Lohia
CEO, Indorama Ventures

Ashok, we really do not know where the oil price will land, but directionally, oil price is going down, would lower our working capital requirement. More importantly, through the S&OE practice that we started this year, we have been able to control our net exposure. So in our quarter three results, there is no impact of inventory gain or lag. They offset each other. This is probably the first quarter where the exposure management has been towards where we want it to be. Further, we continue to try to optimize our inventory turns. So from 5.2 in quarter three, our expectation, our target is to go to six turns, and even higher in 2027. All of these factors release cash and lower debt.

Naphat Chantaraserekul
Analyst, CLSA

Thank you. Maybe just one last question is on the development on the oil market now, because have we seen any change in terms of sales volume in Q4, given oil price are softening at the moment? Thank you.

Aloke Lohia
CEO, Indorama Ventures

Khun Naphat, each business is different from a seasonality point of view. From the oil-related, I do not believe. I think from a, I am giving you my personal opinion. We still do not know where the war is, where the geopolitics is, and whether the war will continue or end, and where finally in 2027, oil will settle down. But there is a whole sense of relief in our downstream, in our customers. Generally, Q4 is the weakest quarter for PET, if you are talking about PET. For our Indovinya business also, quarter four, quarter one are usually the weaker seasonalities.

Usually quarter four is a seasonally weak quarter for IVL businesses. Is that true for fiber as well?

Diego Boeri
Executive President of Fibers, Indorama Ventures

Q3s tend to be weaker because we have the [crosstalk] the summer shutdowns in mobility, and that have a big impact in Europe. Q4 normally is a normal quarter.

Aloke Lohia
CEO, Indorama Ventures

For packaging, is there any difference seasonally-wise?

Sunil Marwah
President of Indovida, Indorama Ventures

The Northern Hemisphere tends to get colder in quarter four, but to some extent, it is offset by the Christmas and the New Year celebrations. On balance, it is marginally lower than quarter three.

Aloke Lohia
CEO, Indorama Ventures

Yeah. All in all, quarter four would be a seasonally low quarter. But there is an element of the, let's say, the downstream beverage companies in PET, they do not have the flexibility of adjusting their end product price. The prices that are prevailing now because of the crude oil reduction could lead to customers making a decision to make longer-term purchases now. Deliveries will happen across 2027, but they could lock in prices today, and I see that potentially happening. So, I think we are basically looking at our business now from an exposure management point of view. So everything we sell, we control with our inventory. And the hand-to-mouth situation that prevailed in the second quarter and third quarter because of the volatility of the geopolitics, I think now there is a little bit more certainty. But let's keep our fingers crossed.

Operator

Okay. Khun Naphat, if you do not have any more questions, we will move on to Kaushal. Kaushal, please unmute your mic and post your questions, please.

Kaushal Ladha
Analyst, Macquarie

Good morning, Mr. Lohia and management. Thank you for the presentation. Three questions from me. Maybe I will ask them one by one. I mean, the first question is just about on self-help. I think roughly THB 10 billion in fixed cost reduction since 2023. I was hoping maybe the management could sort of give us some, how much was the incremental in 2025 and how much nine months to date? And then any sort of guidance in terms of how much more can we expect next year and maybe the year after?

Aloke Lohia
CEO, Indorama Ventures

So that is two questions, is it? On fixed cost, 2025, 2026, and 2027.

Kaushal Ladha
Analyst, Macquarie

Right. Yes.

Aloke Lohia
CEO, Indorama Ventures

Okay. Ashok?

Ashok Jain
CFO, Indorama Ventures

Yeah. We will provide this data to you for each year, 2025, 2026, and 2027. We will send it across through our IR team. But I think the trajectory is to further reduce the fixed cost because there have been certain assets which have been rationalized in 2025, 2026. So those costs will go away in our 2027 numbers. So directionally, our fixed costs are expected to decrease.

Aloke Lohia
CEO, Indorama Ventures

I think I have put some pressure on the corporate side. If you look at the individual, if you put the IVL slide, one would see that our corporate costs have increased in 2026. So this is being understood because the corporate has to be leading with example and improving our cost structure just as well as what we expect from our segments. So do expect 2027 cost structure to improve. Thank you.

Kaushal Ladha
Analyst, Macquarie

Okay. And maybe the next question is for Alastair. I was looking at the Indovinya sort of margins. We have seen a bit of a decline quarter on quarter. But just maybe trying to better understand, has it been because, has there been a change in the product mix or is there sort of lower sort of pricing realization maybe across the different markets or product groups? So just some color on that would be helpful.

Alastair Port
Executive President of Indovinya, Indorama Ventures

Sure. Well, on the quarter, I mean, as I think was said, we have had two quarters running above $500 million of EBITDA. So firstly, two really good quarters. The slight reduction quarter on quarter, nothing really to be majorly concerned about. One was LAB, where we were doing some maintenance in quarter three that we were not doing in quarter two. So there was a reduction on the LAB side. And the other one was on propylene glycol, to be specific, where one of our competitors had an outage in Q2, and we maximized earnings in Q2, and that is sort of obviously normalized to some extent in Q3. The only other real changes was some provisions of fixed costs for end of year, and that was it. Those were the real three changes. The only slight other one was a slight reduction in ethylene margins.

So, maybe about $16 million of EBITDA, which is not significant from our point of view, and still a very, very strong quarter. We did not see any signs in the other businesses, and actually we saw an uptick in some of the HVA businesses versus QonQ and year-on-year. Those are the two or three issues.

Kaushal Ladha
Analyst, Macquarie

Okay, thanks. Maybe just my last question is, maybe for Muthu, we have seen a big jump in the intermediate sort of segment earnings. EG and MTBE cycle has sort of turned around. I am just trying to get a better sense of what is the sort of more sustainable number? We have seen from maybe $30 million last year, the same quarter, to almost $100 million, and it has been very volatile. I am just trying to get a better sense of what would be more sustainable.

Muthukumar Paramasivam
President of CPET, Indorama Ventures

Okay, great. The earnings improvement, as we mentioned earlier, it has come certainly considerably from the margin improvement, but also the volumes. The better reliability that we have been able to make sure that is under the completion of the TAR, those also contributed towards the improvement in performance, and that should be sustainable going forward. As far as the EG margins, as I mentioned earlier, we do expect it to stabilize better than the 2025 levels. Even if there is some moderation that we have seen recently, it is still better. As far as MTBE, of course, there have been specific dynamics and the seasonality that is typical for the spike in MTBE margins. There has been some moderation since then in the recent days and weeks, so there has been moderation on MTBE. Again, here, what I mentioned earlier, that we have this natural operational hedge.

While there will be some moderation on IC, that is also going to result in lower feedstock costs for our U.S.-based paraxylene production. So, there is an offset happening there. Certainly there is some moderation possible on the IC going forward, but still you can see that the performance is considerably better. Hope, Kaushal, that answers your question specific on the spreads.

Aloke Lohia
CEO, Indorama Ventures

This discussion on refineries and intermediate products, this requires a larger discussion. With so many of the Russian refineries attacked, some of the capacities in the Gulf not operating, the difficulty to get tanker fleet to move goods, it taking 45 - 60 days to move goods from one region to another. All this, I think, is going to keep the industry in a more comfortable situation in 2027 than in 2025. Especially if you think of the Chinese, a lot of the downstream products today are produced in integrated complexes. Perhaps in my mind, with the refinery outages in the rest of the world, the Chinese overcapacity that we always talk about, that probably would be able to fill in the gap. Which also means that they will have an option to choose what downstream products and what margins they want for them.

It's a learning that is continuing at this time, and I hope that we have formed a new division in the corporate called Market Intelligence, and we are working with this Market Intelligence team to understand and deeper do our own research on supply and demand of this entire aromatic and olefin chain. Hopefully by the next Capital Markets Day or the fourth quarter results, we would be able to share with you a more detailed version of our own analysis in this respect. Obviously, we are feeling comfortable with where we are today. We are feeling comfortable with where the reset is going to happen for the downstream products because of all this tightness that we have, both in freight as well as in upstream assets. It's still a directional question, but a much more confident situation today than where we were exactly a year ago.

Ashok Jain
CFO, Indorama Ventures

Maybe—

Kaushal Ladha
Analyst, Macquarie

Thank you, Mr. Lohia.

Ashok Jain
CFO, Indorama Ventures

If I may, Kaushal, to your question on the fixed cost. At the end of 2023, we were at THB 84 billion. In 2024, we were at THB 83 billion. This is all net of inflation adjusted, all the three variables which we stated. In 2025, we were at THB 76 billion. So from 2024 to 2025, there was a decrease of THB 7 billion, which reflects the major shutdowns that took place in the middle of 2024 and in the second half of 2024. From 2025 to 2026, it is THB 74 billion. So there is a further decrease of THB 2 billion. We will come back to you with the 2027 number, keeping in mind also the addition of EPL and also the existing portfolio plus the addition of EPL next year.

Kaushal Ladha
Analyst, Macquarie

Thank you, Ashok.

Operator

Okay. Kaushal, do you have any more questions or should we move on?

Kaushal Ladha
Analyst, Macquarie

I am fine, thank you.

Operator

Okay, thanks. Khun Naphat has another question. Khun Naphat, please go ahead.

Naphat Chantaraserekul
Analyst, CLSA

Yeah. Just curious because I do not see any announcement on the quarterly dividend. Are we still sticking to the quarterly dividend pay? Just to give comfort to the minority shareholders.

Aloke Lohia
CEO, Indorama Ventures

Yeah, our board meeting is this week, and I believe that our board likes to have consistent dividend. Once we increased the dividend last board meeting, they wanted to ensure that we could afford to, and we will be consistent with that.

Naphat Chantaraserekul
Analyst, CLSA

Okay, thank you.

Operator

Okay. I don't see any more hands raised. Do we have any more questions? Thank you. It looks like there are no more questions this morning. Thank you very much for attending, and we look forward to seeing you next time. Thank you.

Aloke Lohia
CEO, Indorama Ventures

Thank you.